AstraZeneca Share Price (AZN)

0.00 0.00 (0.00%) delayed: 1:42AM BST
Bid price 5,941.00 Open price 0.00
Ask price 5,942.00 Prev close 5,942.00
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live AstraZeneca share prices, AstraZeneca stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get AstraZeneca Level 2 Data, indepth research tools and investor commentary for AstraZeneca (AZN) and other London Stock Exchange equities.

AstraZeneca Share Price Chart

Advanced Charts >>

Register now for FREE AstraZeneca share price charts

AstraZeneca Share Price Information

Name AstraZeneca Epic AZN
Sector Pharmaceuticals & Biotechnology ISIN GB0009895292
Activites AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Index FTSE 100

AstraZeneca Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 68.49
Market Capitalisation (£m) 76,665.30 Gross Gearing (%) 73.73
Shares in issue (m) 1,266.78 Debt Ratio 64.57
P/E Ratio 25.54 Debt-to-Equity Ratio 0.65
Total dividends per share (p) 202.50 Assets / Equity Ratio 3.81
Dividend Yield (%) 3.34 Price to book value 4.61
Dividend cover (x) 1.17 ROCE (%) 4.74
Earning per share (p) 237.00 EPS Growth (%) -14.44
52 week high / low 6,122.00 / 4,355.00 DPS Growth (%) -7.49

AstraZeneca Director Deals

Dec.Date Type Director Pos No. of Shares
28/03/2018 TIN Pascal Soriot CEO 11,998
28/03/2018 TIN Marc Dunoyer FD 3,768
05/02/2018 BUY Philip Broadley FD 415
15/12/2017 TOUT Pascal Soriot CEO 39,648
28/07/2017 BUY Philip Broadley FD 2,300

More AstraZeneca Director Deals >>

AstraZeneca Company News

08:39 15/08/2018

AstraZeneca prices $3bn bond offering

AstraZeneca said Wednesday it had priced a four tranche global bond offering totalling $3bn earlier this week. The proceeds of the offering - expected to close on Friday - was priced on 14 August, and would be used for general corporate purposes, which may include the refinancing of existing...

07:00 15/08/2018

AstraZeneca prices a $3bn bond issue

RNS Number : 8190X AstraZeneca PLC 15 August 2018   15 August 2018 07:00 BST   AstraZeneca prices a $3bn bond issue   AstraZeneca PLC announces that, on 14 August 2018, it priced a four tranche global bond offering totalling $3bn. The offering is expected to...

08:30 03/08/2018

AstraZeneca neurofibromatosis treatment granted orphan status in EU

AstraZeneca on Friday said European regulators had granted orphan designation to the company's neurofibromatosis type 1 treatment. Orphan designation is a status assigned to a medicine intended for use in rare diseases. Neurofibromatosis type 1, or NF1, is an incurable genetic condition that...

More AstraZeneca Company News >>

Register now for FREE AstraZeneca company news

AstraZeneca Share Price Discussions

3 months ago

Any views on Astrazeneca (AZN)

Got a good line of products, but the share price seem to go down , could it be due to the weak us dollar.

more than 1 year ago

Two Peaches!!!! (AZN)

(option stock price + price paid) (stock option sell price chnge on day for option) LOG MAY 280 PUT 23+6 263 24 AZN MAY 2600 PUT 104+25 2548 118 THESE WILL MOVE QUICKLY!

more than 1 year ago

FTSE signals (AZN)

FTSE 100 :4410.7+25 @16:36 MAIN S/R 4518 TARGET 4375/1 MINI S/R 4446 TARGET 4357/1 VOL 2850 YIELD 3.26 BAROMETER 32 LONG FTSE FUTURE (JUN 04) ARE @ 4423, 13 POINTS ABOVE CASH AND 1.5 ABOVE FAIR VALUE OF +11.5 DOW @ 10396+39 @ 17:00 (PUT YOUR SHORTS ON!!)

Register now for FREE AstraZeneca share price discussions